Ageing and hormones

European Journal of Clinical Investigation

Volumn 29, Issue 3, 1999, Pages 210-213

  Roshan, S ^a   Nader, S ^a   Orlander, P ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Ageing; Dehydroepiandrosterone; Growth hormone; Hormones; Oestrogen; Testosterone

Indexed keywords

ESTROGEN; GROWTH HORMONE; PRASTERONE; TESTOSTERONE; HORMONE; HUMAN GROWTH HORMONE;

ADULT; AGED; AGING; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SHORT SURVEY; METABOLISM; REVIEW;

AGING; DEHYDROEPIANDROSTERONE; ESTROGENS; HORMONE REPLACEMENT THERAPY; HORMONES; HUMAN GROWTH HORMONE; HUMANS; TESTOSTERONE;

EID: 0033088329     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00436.x     Document Type: Short Survey

References (26)

1. 1 Tenover JL. Testosterone and the aging male. J Androl 1997;18 (2):103-6.
2. 2 Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentration throughout adulthood. J Clin Endocrinol Metab 1984;59:551-5.
3. 3 Veldhuis JD, Liem AY, South S, et al. Differential impact of age, sex, steroid hormones, and obesity on basal vs. pulsatile growth hormone secretion in men assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 1995;80:3209-22.
4. 4 Veldhuis JD, Iranmanesh A, Ho KK, Lizarralde G, Waters MJ, Johnson ML. Dual defects in pulsatile GH secretion and clearance subserve the hyposmatotropism of obesity in man. J Clin Endocrinol Metab 1991;72:51-9.
5. 5 Alsina JC. Benefits of hormone replacement therapy. Int J Fertil 1997;2 (Suppl.):329-46.
6. 6 Tenover ST. Androgen administration to aging men. Clin Androl 1994;23:877-87.
7. 7 Nankin HR, Calkins JG. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab 1986;63:1418-20.
8. 8 Korenman SG, Morely JE, Mooradian AD, et al. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 1990;71:963-9.
9. 9 Sih R, Morley JE, Kaiser FE, et al. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661-7.
10. 10 Hajjar RR, Kaiser FE, Morley JE. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 1997;82: 3793-6.
11. 1 levels. Nature Med 1997;3:1209-15.
12. 12 De Peretti E, Forest M. Unconjugated DHEA plasma levels in normal subjects from birth to adolescence in humans. J Clin Endocrinol Metab 1976;43:982-90.
13. 13 Nestler JE, Barlascini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988;66:57-61.
14. 14 Morales AJ, Nolan JJ, et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-7.
15. 15 Mortola JF, Yen SSC. The effects of dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990;71:696-704.
16. 16 Labrie F, Diamond P, Cusan L, Gomez J, Belanger A, Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997;82:3498-505.
17. 17 Hoffman D, O'Sullivan AJ, Baxter RC, Ho KKY. Diagnosis of growth-hormone deficiency in adults. Lancet 1994;343:1064-8.
18. 18 Carroll P, Christ E. members of Growth Hormone Research Society Scientific Committee. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998;83:382-95.
19. 19 Consensus Guidelines For The Diagnosis And Treatment Of Adults With Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-81.
20. 20 Aimaretti G, Corneli G, Razzore P, et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + Arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998;83:1615-8.
21. 21 Johannsson G, Rosen T, Bosaeus I, Sjostorm L, Bengtsson BA. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1996;81:2865-73.
22. 22 Baum HB, Biller BM, Finkelstein JS, et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset of growth hormone deficiency. Ann Intern Med 1996;125:883-90.
23. 23 Gomberg-Maitland M, Frishman WH. Recombinant growth hormone: a new cardiovascular drug therapy. Am Heart J 1996;132:1244-62.
24. 24 Guistina A, Lorusso R, Borghetti V, Bugari G, Misitano V, Alfieri O. Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. Am Heart J 1996;131:620-2.
25. 25 Fazio S, Sabatini D, Capaldo B, et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996;334:809-14.
26. 26 Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women: potential remedial effects. Ann NY Acad Sci 1995;774:128-42.